Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RYTM
Stock Latest News
The Fly
Rhythm Pharmaceuticals price target raised to $141 from $137 at RBC Capital
4d ago
RYTM
Premium
Company Announcements
Rhythm Pharmaceuticals Stockholders Back Board, Governance Proposals
15d ago
8K
RYTM
Premium
TipRanks Newswire
Palatin Technologies Is Pursuing the Next Generation of MC4R. Rhythm Just Reinforced Why That Matters
23d ago
LLY
NVO
Premium
Ratings
Rhythm Pharmaceuticals: Buy Rating Reaffirmed as Strong PWS Data Lift 2033 Outlook and Price Target Raised to $151 from $143
25d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $151 from $143 at Canaccord
25d ago
RYTM
Premium
Company Announcements
Rhythm Showcases Positive Setmelanotide Data Across Obesity Trials
25d ago
8K
RYTM
Premium
Ratings
Buy Rating Reaffirmed on Rhythm as PWS Data Strengthens Thesis; $136 Price Target Maintained
26d ago
RYTM
Premium
Ratings
Rhythm Pharmaceuticals: Phase 2 PWS Data Strengthen Outlook as Buy Rating and $130 Price Target Are Reaffirmed
26d ago
RYTM
Premium
Ratings
Rhythm Pharmaceuticals: Buy Rating Reiterated on Promising PWS Data and Large Market Opportunity; $105 Price Target Unchanged
26d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $155 from $144 at Wells Fargo
26d ago
RYTM
Premium
The Fly
Rhythm announces preliminary data from Phase 2 trial of setmelanotide
26d ago
RYTM
Premium
Company Announcements
Rhythm Pharmaceuticals Signals Momentum Despite Rising Costs
2M ago
RYTM
Premium
The Fly
Aardvark Therapeutics downgraded to Underperform from Buy at BofA
2M ago
AARD
NBIX
Premium
TipRanks Newswire
Palatin Is Betting on the Next Generation of Obesity Drugs (NYSE: PTN)
2M ago
NVO
PTN
Premium
Ratings
Buy Rating Reiterated as IMCIVREE Adoption Outpaces Expectations; $105 Price Target Maintained
2M ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $143 from $140 at Canaccord
2M ago
RYTM
Premium
Company Announcements
Rhythm Pharmaceuticals Bets Big On Obesity Growth
2M ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals reports Q1 EPS (83c), consensus (86c)
2M ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals sees FY26 operating expenses $385M-$415M
2M ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals presents Phase 3 TRANSCEND trial data
2M ago
RYTM
Premium
Pre-Earnings
RYTM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals’ Imcivree granted MAA in Europe for obesity
2M ago
RYTM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
